How to improve the cancer continuum for transgender and gender-diverse patients
Transgender and gender-diverse patients experience significant disparities throughout the cancer continuum, including receiving less frequent preventive cancer screenings for all cancer types, being diagnosed with cancer at later stages, and being less likely to receive treatment for some types of cancer. This brief correspondence describes steps that providers and institutions can take to improve research, provider training, and clinical care for this vulnerable population.
Authors
- Theodore E. Schall (ORCID: https://orcid.org/0000-0002-0353-2657)
- NFN Scout (ORCID: https://orcid.org/0000-0001-5485-6152)
- Adrian Shanker (ORCID: https://orcid.org/0000-0002-6191-7889)
- Laura E Stamm
Institutions
- Lehigh University (US)
- University of Massachusetts Amherst (US)
- Pancreatic Cancer Action Network (US)
- University of Rochester Medical Center (US)
Publication Details
- Journal
- JNCI Cancer Spectrum
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1093/jncics/pkaf120
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00